Midatech Pharma Share Discussion Threads

[genierub] 25/1/2019 15:18

N4P about to rocket in the last hour. GLA.

[sunnybeachboy] 25/1/2019 14:59

Ask 4pSnooze you loose...

[sunnybeachboy] 25/1/2019 14:51

3.9p paid.

[sunnybeachboy] 25/1/2019 14:36

Bid 3.5pThis will close at 4p Well oversold.

[sunnybeachboy] 25/1/2019 14:34

Bid 3.4pAsk 3.6pUp we go peeps

[pythian] 25/1/2019 14:32

Well said, as ever, researchanalyst! It's definitely worth a punt on the very basis that you point out. If this share was ever worth anything, it is certainly not worth less now than it was last month. I've doubled my holding today: that should have the pusillanimous running to press the buy button. It's not every day that I risk 1200 quid. LOL.

jonwig would never approve (assuming that you were the one who tortured him to the point of surrender): that's another good reason to buy!

[sunnybeachboy] 25/1/2019 14:21

Ask moved up 3.5p

[sunnybeachboy] 25/1/2019 14:13

Ask up 3.4p

[sunnybeachboy] 25/1/2019 13:49

Just took 300,000@3.27p

[tomboyb] 25/1/2019 13:05

i took a few earlier with a view around 4-5p -

High risk as monies required urgently -

[hope67] 13/1/2019 20:41

Have a listen especially at the end they want to keep the Nasdaq listing hxxp://www.midatechpharma.com/audio/180928%20Midatech%20Pharma.mp3

[hope67] 13/1/2019 20:39

hxxps://www.proac tiveinvestors.co.uk/companies/news/203950/big-names-in-pharma-starting-to-take-note-of-midatech-pharma-s-drug-delivery-technology-203950.html

[hope67] 13/1/2019 20:36

hxxp://www.midatechpharma.com/uploads/investor_files/180927%20Interims%20September%202018%20Final.pdf

[hope67] 11/1/2019 20:12

Worth a read htxp://www.evaluate.com/vantage/articles/interviews/midatech-hopes-find-golden-touch-new-focus

[hope67] 11/1/2019 20:11

Look at the volume on the 10th in the Us hxxp://www.stockhouse.com/companies/quote?symbol=mtp

[hope67] 11/1/2019 20:10

1 November 2018

Midatech Pharma PLC

("Midatech", "Company" or "Group")

NASDAQ Minimum Bid Price Extension

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the R&D company focused on delivering innovative oncology and rare disease products to patients, announces that, as previously disclosed, on 1 May, 2018, Midatech Pharma PLC (the "Company") received a letter ("Notification Letter") from The Nasdaq Stock Market LLC ("NASDAQ") providing notification that, for the previous 30 consecutive business days, the bid price for the Company's American Depositary Shares had closed below the minimum $1.00 bid price per share requirement for continued listing on The NASDAQ Capital Market under NASDAQ Listing Rule 5550(a)(2). Each American Depositary Share represents two ordinary shares of the Company.

On 30 October 2018, the Company was notified by NASDAQ that its American Depositary Shares have not regained the minimum $1.00 bid price per share requirement within the 180 calendar days following receipt of the Notification Letter. However, NASDAQ has determined that the Company is eligible for an additional 180 calendar day period, pursuant to NASDAQ Listing Rule 5810(c)(3)(A), or until 29 April 2019, to regain the minimum $1.00 bid price per share requirement. This will be met if, at any time during this 180 days period, the closing bid price of the Company's American Depositary Shares is at least $1.00 for a minimum of ten consecutive business days.

[tomboyb] 10/1/2019 15:55

250k in at 6.5p -

There is a BUYER and SELLER here -

[tomboyb] 10/1/2019 15:53

6.49p is ask now -